[Experience with Cosaldon retard in double blind studies].
D000368:Aged; D000375:Aging; D001921:Brain / Q000378:metabolism; D002561:Cerebrovascular Disorders / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D005853:Geriatrics; D006801:Humans; D009539:Nicotinic Acids / Q000627:therapeutic use; D013805:Theobromine / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000627:therapeutic use*
D009539:Nicotinic Acids; D014665:Vasodilator Agents; D013805:Theobromine
Erfahrungen mit Cosaldon retard im Doppelblindversuch.